FABIO ECHAVARRIA: Open Payments
NPI 1710984687 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$775 in 38 payments from 12 companies in 2025. Trend: 2023 $625 · 2024 $873 · 2025 $775
Food & beverage: $775
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $170 |
| Amgen Inc. | 6 | $111 |
| AstraZeneca Pharmaceuticals LP | 5 | $108 |
| PFIZER INC. | 5 | $99 |
| Exact Sciences Corporation | 3 | $69 |
| Lilly USA, LLC | 3 | $56 |
| Eisai Inc. | 2 | $50 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Corcept Therapeutics | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: OTEZLA, Cologuard Collection Kit, FARXIGA, Leqembi, Ozempic, Wegovy, NURTEC ODT, KRYSTEXXA.
Industry payments across FL — which companies pay providers there.
